Abstract:In this research, polyethylenimine-functionalized gold nanoclusters (PEI-AuNCs) were synthesized for the delivery of plasmid CMTM5 (pCMTM5) to prostate cancer (PCa) cells, with the objective of elucidating the mechanism underlying its anticancer efficacy. The PEI-AuNCs loaded with pCMTM5 (PEI-AuNCs@pCMTM5) tumor-targeting drug delivery system was established. Subsequently, both the obtained PEI-AuNCs and PEI-AuNCs@pCMTM5 underwent characterization through a transmission electron microscope (TEM) and dynamic light scattering (DLS). Employing RT-qPCR, western blot, flow cytometry, immunofluorescence, and co-immunoprecipitation (co-IP) assays, the consequences of CMTM5 overexpression on the expression of EGFR were investigated. Moreover, the influence of PEI-AuNCs@pCMTM5 on PC-3 cells was assessed through CCK-8, wound healing assay, and Transwell experiments. As a result, the PEI-AuNCs and PEI-AuNCs@pCMTM5 were presented as uniformly dispersed spherical with stable particle sizes and positive charges, showcasing favorable dispersion within the solution. In comparison to Lip2000, the PEI-AuNCs demonstrated superior transfection efficiency and lower cellular toxicity. Following the overexpression of CMTM5, the proliferative capacity of PC-3 cells was markedly suppressed, while both migratory and invasive abilities exhibited noteworthy reduction, with the efficacy of PEI-AuNCs@pCMTM5 consistently outperforming that of free pCMTM5. Subsequent mechanistic investigations unveiled that CMTM5 does not directly inhibit the synthesis of EGFR or facilitate its degradation, but rather influences the endocytic process of EGFR. In conclusion, the PEI-AuNCs nano-delivery system exhibits good biocompatibility and efficaciously conveys pCMTM5 to PCa cells. Crucially, pCMTM5 does not directly interact with EGFR, and CMTM5 governs the malignant progression of PC3 cells by promoting EGFR endocytosis.

Effect of CMTM5 on Prostate Cancer Cell Proliferation, Migration and Invasion

Inhibitory Effect of CMTM5 on Xenografted Human Prostatic Cancer in Nude Mice

CMTM5 is reduced in prostate cancer and inhibits cancer cell growth in vitro and in vivo

CMTM5-v1 inhibits cell proliferation and migration by downregulating oncogenic EGFR signaling in prostate cancer cells

[CMTM5 Inhibits the Tumor Cell Behavior of Prostate Cancer by Downregulation of HER2].

Research advances in CKLF-like MARVEL transmembrane domain containing member 5]

[Expression and Significance of CMTM5 and Epidermal Growth Factor Receptor in Prostate Cancer].

Effects of KMT5A on cell migration and invasion in human hepatocellular carcinoma and its mechanisms

Tadalafil increases the antitumor activity of 5-FU through inhibiting PRMT5-mediated glycolysis and cell proliferation in colorectal cancer

Cmtm5 Induces Apoptosis of Pancreatic Cancer Cells and Has Synergistic Effects with Tnf-Alpha

The role of polyethylenimine-functionalized gold nanoclusters carrying plasmid CMTM5 in impeding the malignant progression of prostate cancer cells by promoting EGFR endocytosis

CMTM5 is Downregulated and Suppresses Tumour Growth in Hepatocellular Carcinoma Through Regulating PI3K-AKT Signalling

The Effect of Mast Cells on the Biological Characteristics of Prostate Cancer Cells

Downregulation of CDCA5 Can Inhibit Cell Proliferation, Migration, and Invasion, and Induce Apoptosis of Prostate Cancer Cells

Effects of CCL5 on the biological behavior of breast cancer and the mechanisms of its interaction with tumor‑associated macrophages

AB179. CMTM3 is Reduced in Prostate Cancer and Inhibits Migration, Invasion and Growth of LNCaP Cells

[Knockdown of CMTM3 Promotes Migration and Invasion of PC3 Cell in Vitro].

CMTM5-v1 induces apoptosis in cervical carcinoma cells.

Overexpression of ADAMTS5 Can Regulate the Migration and Invasion of Non-Small Cell Lung Cancer

The effect of PAGE5 expression on growth,apoptosis and invasion of non -small cell lung cancer cells

Bioinformatics-Based Discovery of CKLF-Like MARVEL Transmembrane Member 5 As a Novel Biomarker for Breast Cancer.